Literature DB >> 9228067

Function of the type V transforming growth factor beta receptor in transforming growth factor beta-induced growth inhibition of mink lung epithelial cells.

Q Liu1, S S Huang, J S Huang.   

Abstract

The type V transforming growth factor beta (TGF-beta) is a 400-kDa nonproteoglycan membrane protein that co-expresses with the type I, type II, and type III TGF-beta receptors in most cell types. The type V TGF-beta receptor exhibits a Ser/Thr-specific protein kinase activity with distinct substrate specificity (Liu, Q., Huang, S. S., and Huang, J. (1994) J. Biol. Chem. 269, 9221-9226). In mink lung epithelial cells, the type V TGF-beta receptor was found to form heterocomplexes with the type I TGF-beta receptor by immunoprecipitation with antiserum to the type V TGF-beta receptor after 125I-TGF-beta affinity labeling or Trans35S-label metabolic labeling of the cells. The kinase activity of the type V TGF-beta receptor was stimulated after treatment of mink lung epithelial cells with TGF-beta. TGF-beta stimulation resulted in the growth inhibition of wild-type mink lung epithelial cells and to a lesser extent of the type I and type II TGF-beta receptor-defective mutants, although higher concentrations of TGF-beta were required for the growth inhibition of these mutants. TGF-beta was unable to induce growth inhibition in human colorectal carcinoma cells lacking the type V TGF-beta receptor but expressing the type I and type II TGF-beta receptors. These results suggest that the type V TGF-beta receptor can mediate the TGF-beta-induced growth inhibitory response in the absence of the type I or type II TGF-beta receptor. These results also support the hypothesis that loss of the type V TGF-beta receptor may contribute to the malignancy of certain carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9228067     DOI: 10.1074/jbc.272.30.18891

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  LRP1-dependent endocytic mechanism governs the signaling output of the bmp system in endothelial cells and in angiogenesis.

Authors:  Xinchun Pi; Christopher E Schmitt; Liang Xie; Andrea L Portbury; Yaxu Wu; Pamela Lockyer; Laura A Dyer; Martin Moser; Guojun Bu; Edward J Flynn; Suk-Won Jin; Cam Patterson
Journal:  Circ Res       Date:  2012-07-09       Impact factor: 17.367

2.  LRP1 Deficiency in Vascular SMC Leads to Pulmonary Arterial Hypertension That Is Reversed by PPARγ Activation.

Authors:  Laurent Calvier; Philippe Boucher; Joachim Herz; Georg Hansmann
Journal:  Circ Res       Date:  2019-04-26       Impact factor: 17.367

3.  The Twisted gastrulation family of proteins, together with the IGFBP and CCN families, comprise the TIC superfamily of cysteine rich secreted factors.

Authors:  P Vilmos; K Gaudenz; Z Hegedus; J L Marsh
Journal:  Mol Pathol       Date:  2001-10

4.  Transforming growth factor beta stimulation of colorectal cancer cell lines: type II receptor bypass and changes in adhesion molecule expression.

Authors:  M Ilyas; J A Efstathiou; J Straub; H C Kim; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

5.  Adenovirus E1A and E1B-19K proteins protect human hepatoma cells from transforming growth factor beta1-induced apoptosis.

Authors:  Vera L Tarakanova; William S M Wold
Journal:  Virus Res       Date:  2009-10-23       Impact factor: 3.303

6.  LRP1 functions as an atheroprotective integrator of TGFbeta and PDFG signals in the vascular wall: implications for Marfan syndrome.

Authors:  Philippe Boucher; Wei-Ping Li; Rachel L Matz; Yoshiharu Takayama; Johan Auwerx; Richard G W Anderson; Joachim Herz
Journal:  PLoS One       Date:  2007-05-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.